News
 

To determine whether a history of cerebrovascular disease (CVD) increases risk of severe coronavirus disease 2019 (COVID-19) a retrospective multicenter study has been conducted from COVID-19 registries of three hospitals in Saxony, Germany.

Infection increases mortality risk among patients with dementia, new research suggests.

Many emergency physicians use an intravenous fluid bolus as part of a 'cocktail' of therapies

Atherosclerosis of the internal carotid artery (ICA) is an important cause of ischemic stroke. Artery-to-artery embolism is the major stroke mechanism in patients with atherosclerotic carotid disease. This study published in BMC Neurology (20, Article number: 288 (2020) hypothesized that the atherosclerotic ICA geometry and plaque location would be...

The novel, orally administered calcitonin gene-related peptide (CGRP) antagonist atogepant has met the primary endpoint

According to this meta-analysis, recently published in Memory & Cognition, music training has no significant effect on cognition.

Modifying 12 risk factors over the life course could delay or prevent 40% of dementia cases, a new report suggests.

Australian researchers have made a breakthrough in Alzheimer's research, demonstrating what they describe as the first gene therapy-based approach to treating advanced forms of the disease.

During this Summer we have extended our consultation hours to Wednesdays and Fridays in order to provide better care and reduce waiting lists caused by confinement.

In the last number of Neurology®, a team representing the Aspirin in Reducing Events in the Elderly (ASPREE) study reports the cognitive outcomes from low-dose aspirin (100 mg/d) therapy vs placebo in elderly individuals who were free of cardiovascular disease, physical disability, or diagnosed dementia.